Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Aug 2021 for Prostatype Genomics AB, €6,326.
Filing timeline
BuySaleMichael Carl Ewert af Winklerfelt
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael Carl Ewert af Winklerfelt: trading record in brief
One trade, one date: on 31 August 2021, Michael Carl Ewert af Winklerfelt disclosed an open-market purchase of €6,326 in Prostatype Genomics AB. No broader history exists yet. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael Carl Ewert af Winklerfelt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 4,000 shares@ SEK 16.10AktieISIN SE0014684569FI:csv-9c587e1670f83b830754Canonical exit: 28 Nov 2021 (T+90)
1 of 1 declaration